This website uses cookies to enhance the user experience.
ARCTICZYMES AS

ARCTICZYMES AS994 191 632

Process industry
Limited company
Forskningsparken Sykehusvegen 23 9019 TROMSØ, Norge

ARCTICZYMES AS

Enzymes for Biomanufacturing, Research, MDx | ArcticZymes
The Enzymes Experts | Solutions for molecular research, diagnostics, and therapeutics for gene therapy, vaccine production. Inventor of salt-active nucleases for biomanufacturing

Keywords

manufacturingchemicalsthermal crackingdistillationbasic chemicalsacyclic hydrocarbonscyclichydrocarbonsacyclicalcoholsmonocarboxylic acidspolycarboxylic acidsacetic acidaldehydesketonesquinonesglycerolaminesestersaromatic products

Links

Organization

Chairman of the board
Years since formation
15 years
since Jun 15, 2009
Type
Limited company
VAT registered
Yes
Number of employees
52

Ownership

Number of shares and share classes
109,380
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2023
119,650,193
NOK
Annual total result 2023
23,597,176
NOK
Total equity 2023
57,322,587
NOK
Last update: Nov 21, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
Board Member-

Others

NameRoleShares
P
PRICEWATERHOUSECOOPERS AS
Auditor-

Top 10 individual shareholders

NameRoleShares
-
4.23 %
indirectly
-
2.24 %
indirectly
-
1.66 %
indirectly
-
1.25 %
indirectly
-
1.21 %
indirectly
-
1.18 %
indirectly
-
1.1 %
indirectly
Last update: Oct 27, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
A
Ordinary shares
109,380
100 %
Last update: May 24, 2024

Group structure

Financials

in NOK

Summary

Year202320222021
Total operating income
119,650,193
137,638,000
129,924,850
Annual Total Result
23,597,176
56,918,000
57,994,194
Total assets
111,563,248
138,880,000
136,770,333
Total liabilities
54,240,661
85,722,000
86,350,991
Total equity
57,322,587
53,158,000
50,419,342

P&L

Year202320222021
Total operating income
119,650,193
137,638,000
129,924,850
Total operating costs
96,493,150
83,350,000
56,647,539
Operating result
23,157,043
54,288,000
73,277,310
Financial income/costs
586,143
3,081,000
787,423
Profit before tax
23,743,186
57,369,000
74,064,733
Total tax & extraordinary income/cost
146,010
451,000
16,070,539
Annual Total Result
23,597,176
56,918,000
57,994,194

Balance overview

Year202320222021
Total fixed assets
53,265,129
38,148,000
14,004,745
Total current assets
58,298,120
100,733,000
122,765,588
Total assets
111,563,248
138,880,000
136,770,333
Short term debt
45,452,231
75,172,000
86,295,876
Long term debt
8,788,430
10,550,000
55,115
Total liabilities
54,240,661
85,722,000
86,350,991
Contributed capital
29,185,553
26,009,000
24,295,800
Retained earnings
28,137,034
27,150,000
26,123,542
Total equity
57,322,587
53,158,000
50,419,342
Total equity and liabilities
111,563,248
138,880,000
136,770,333

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
20
Activity
Manufacture of chemicals and chemical products
20.1
Main industrial group
Manufacture of basic chemicals, fertilisers and nitrogen compounds, plastics and synthetic rubber in primary forms
20.14
Industrial group
Manufacture of other organic basic chemicals
20.140
Industrial group
Manufacture of other organic basic chemicals